KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Non Operating Income (2017 - 2021)

Historic Non Operating Income for LifeMD (LFMD) over the last 3 years, with Q4 2021 value amounting to $2.6 million.

  • LifeMD's Non Operating Income fell 7103.73% to $2.6 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$52000.0, marking a year-over-year decrease of 10066.97%. This contributed to the annual value of $56000.0 for FY2024, which is 2112.68% down from last year.
  • According to the latest figures from Q4 2021, LifeMD's Non Operating Income is $2.6 million, which was down 7103.73% from -$1.8 million recorded in Q3 2021.
  • LifeMD's Non Operating Income's 5-year high stood at $9.1 million during Q4 2020, with a 5-year trough of -$1.8 million in Q3 2021.
  • Moreover, its 3-year median value for Non Operating Income was -$291096.0 (2020), whereas its average is $815087.4.
  • Data for LifeMD's Non Operating Income shows a peak YoY increase of 10573.12% (in 2021) and a maximum YoY decrease of 52686.43% (in 2021) over the last 5 years.
  • Quarter analysis of 3 years shows LifeMD's Non Operating Income stood at -$377213.0 in 2017, then skyrocketed by 2506.6% to $9.1 million in 2020, then plummeted by 71.04% to $2.6 million in 2021.
  • Its last three reported values are $2.6 million in Q4 2021, -$1.8 million for Q3 2021, and -$901910.0 during Q2 2021.